The Investor Relations website contains information about REX American Resources Corporation's business for stockholders, potential investors, and financial ...
Missing: reph | Show results with:reph
$2.98
Investor Contacts. Company. Narayan Prabhu, CFO Reviva Pharmaceuticals. Phone: 408.501.8881. Email: info.rp@revivapharma.com. Investor Relations. Ben Shamsian
Nov 23, 2021 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Slide 1. Investor Presentation May 2021 Exhibit 99.1 · Slide 2. Non-GAAP To supplement our financial results determined by U.S. generally accepted accounting ...
Investor presentations; helloShareholder information · Results · Annual reports ... Relations with shareholders · Internal controls · Tax principles · Articles of ...
Missing: reph | Show results with:reph
Below are the latest news stories about Recro Pharma Inc that investors may wish to consider to help them evaluate REPH as an investment opportunity. Recro ...
Missing: relations | Show results with:relations
As of February 28, 2020, there were 23,401,633 shares of common stock outstanding, par value $0.01 per share. DOCUMENTS INCORPORATED BY REFERENCE. Part III of ...
Recro Pharma (REPH) Investor Presentation - Slideshow. November 23, 2021 - Seeking Alpha. No summary ...
Provides main business data and analysis of RECRO PHARMA INC (REPH), including historical and latest revenues, costs, and profits.
Investor Relations · Corporate Overview · Resideo Highlights · Latest Quarterly Reports · Latest Presentation · Latest Events · Latest News · Quick Links · Email Alert ...
Missing: reph | Show results with:reph